Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase
Clinical Science · 2024
DOI: 10.1042/cs20240447 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Science, 2024. Verfasst von John Tengbom und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Arginase, Diabetes Mellitus, Type 2, Erythrocytes, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, EFSD/Novo Nordisk Foundation Future Leaders Award, Foundation for Geriatric Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The mechanisms underlying endothelial dysfunction in Type 1 and Type 2 diabetes (T1DM and T2DM) are unresolved. The red blood cells (RBCs) with increased arginase activity induce endothelial dysfunction in T2DM, but the implications of RBCs and the role of arginase inhibition in T1DM are unexplored. We aimed to investigate the differences in endothelial function in patients with T1DM and T2DM, with focus on RBCs and arginase. Thirteen patients with T1DM and twenty-six patients with T2DM, matched for HbA1c and sex were included. In vivo endothelium-dependent and -independent vasodilation (EDV and EIDV) were assessed by venous occlusion plethysmography before and after administration of an arginase inhibitor. RBCs were co-incubated with rat aortic segments for 18h followed by evaluation of endothelium-dependent (EDR) and -independent relaxation (EIDR) in isolated organ chambers. In vivo EDV, but not EIDV, was significantly impaired in patients with T2DM compared with patients with T1DM. Arginase inhibition resulted in improved EDV only in T2DM. RBCs from patients with T2DM induced impaired EDR but not EIDR in isolated aortic segments, whereas RBCs from patients with T1DM did not affect EDR nor EIDR. The present study demonstrates markedly impaired EDV in patients with T2DM in comparison with T1DM. In addition, it highlights the divergent roles of RBCs and arginase in mediating endothelial dysfunction in T1DM and T2DM. While endothelial dysfunction is mediated via RBCs and arginase in T2DM, these phenomena are not prominent in T1DM thereby indicating distinct differences in underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Division of Endocrinology and Diabetology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Division of Endocrinology, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
ORCID-Profile: John Tengbom
Förderung
- Swedish Research Council
- EFSD/Novo Nordisk Foundation Future Leaders Award
- Foundation for Geriatric Diseases
- Hjärt-Lungfonden (Swedish Heart-Lung Foundation)
Zitieren
APA
Tengbom, J., Kontidou, E., Collado, A., Yang, J., Alvarsson, M., Brinck, J., Rössner, S., Zhou, Z., Pernow, J., & Mahdi, A. (2024). Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase. Clinical Science. https://doi.org/10.1042/cs20240447
Vancouver
Tengbom J, Kontidou E, Collado A, Yang J, Alvarsson M, Brinck J, et al. Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase. Clinical Science. 2024. doi:10.1042/cs20240447
BibTeX
@article{Tengbom2024,
author = {Tengbom, John and Kontidou, Eftychia and Collado, Aida and Yang, Jiangning and Alvarsson, Michael and Brinck, Jonas and Rössner, Sophia and Zhou, Zhichao and Pernow, John and Mahdi, Ali},
title = {Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginase},
journal = {Clinical Science},
year = {2024},
doi = {10.1042/cs20240447}
}
EUVIMED